Showing results (151-160 of 1,577) with videos related to

Sort By:
Pageof 158
American Journal of Clinical Dermatology|January 12, 2017
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)Andrew Blauvelt, Kim A Papp, Christopher E M Griffiths, et al.
American Journal of Clinical Dermatology|April 3, 2019
Psychological Therapies in Management of Psoriatic Skin Disease: A Systematic ReviewAzam A Qureshi, Olabola Awosika, Francesca Baruffi, et al.
American Journal of Clinical Dermatology|March 29, 2019
Active Tuberculosis in Patients with Psoriasis Receiving Biologic Therapy: A Systematic ReviewIgor Snast, Einav Bercovici, Efrat Solomon-Cohen, et al.
American Journal of Clinical Dermatology|April 30, 2015
Hand dermatitis: a review of clinical features, prevention and treatmentDimitar Antonov, Sibylle Schliemann, Peter Elsner
American Journal of Clinical Dermatology|May 13, 2015
Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexateMichael E Farhangian, Steven R Feldman
American Journal of Clinical Dermatology|August 26, 2025
Lichen Simplex Chronicus: Clinical Perspectives and Emerging Therapeutic StrategiesMichal Moshkovich, Luis F Andrade, Mike Anderson, et al.
American Journal of Clinical Dermatology|April 24, 2015
The times they are a-changin': new antibacterials for skin and skin structure infectionsMai-Chi N Tran, Snezana Naumovski, Ellie J C Goldstein
American Journal of Clinical Dermatology|August 3, 2016
Critical Evaluation of Delayed Healing of Venous Leg Ulcers: A Retrospective Analysis in Canadian PatientsGary K Yang, Sarah Cao, Ahmed Kayssi, et al.
American Journal of Clinical Dermatology|August 31, 2025
Bimekizumab Complete Clearance of Both Skin and Nail Psoriasis: Comparative Efficacy in Phase III/IIIb StudiesJoseph F Merola, Richard B Warren, Diamant Thaçi, et al.
American Journal of Clinical Dermatology|June 10, 2015
Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticariaMichael S Broder, Karina Raimundo, Evgeniya Antonova, et al.
Pageof 158